Latest filing published 18 Jun 2022 for Lipigon Phartmaceuticals AB, €4,819.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael James Owens: trading record in brief
This profile gathers the share dealings of Michael James Owens in Lipigon Phartmaceuticals AB. Over a trading history stretching from 21 June 2021 to 17 June 2022, the count stands at 3 filings.
No open-market sale appears; the market trades are 2 purchases worth €13k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 18 June 2022 with a transaction (€4,819) in Lipigon Phartmaceuticals AB. The clock since the last published purchase (23 June 2021) now reads 1,965 days. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael James Owens
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,000 shares@ SEK 2.1526.6% of flowBTA (betald tecknad aktie)ISIN SE0017911613FI:csv-885a8bf8d1e463fcf9af
- 10,000 shares@ SEK 6.7557.9% of flowAktieISIN SE0015382072FI:csv-89670f6e56f99e1f4d49Canonical exit: 19 Sept 2021 (T+90)
2 of 2 declarations